M 14 (Methotrexate 2.5 mg)
Pill imprint M 14 has been identified as Methotrexate sodium 2.5 mg.
Methotrexate is used in the treatment of rheumatoid arthritis; psoriasis; psoriatic arthritis; acute lymphoblastic leukemia; dermatomyositis (and more), and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants. Not for use in pregnancy. Methotrexate 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- M 14
- 2.5 mg
- 6.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium carbonate monohydrate
sodium lauryl sulfate
sodium starch glycolate type A potato
FD&C Red No. 40
|NDC Code||Manufacturer / Repackager|
|51079-0670||UDL Laboratories Inc|
|21695-0111||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
More about methotrexate
- Methotrexate tablets
- Methotrexate injection
- Methotrexate (Advanced Reading)
- Methotrexate Oral, Injection (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.